Market Data 
Markets
Replies to post #176958 on Biotech Values
05/08/14 3:01 PM
Price caps will be lifted for 280 medicines made by Western drug companies and 250 Chinese patent drugs, the National Development and Reform Commission, China's economic planning body, said in a statement Thursday.
…The pricing reversal comes as some manufacturers—aiming to meet low-cost standards—cut corners on production, exposing consumers to safety risks, said Helen Chen, a Shanghai-based partner and director of L.E.K. Consulting. medication. "It means the Commission recognizes that forcing prices down and focusing purely on price does sacrifice drug safety, quality and availability," said Ms. Chen.
AI
